Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Canine pemphigus foliaceus involves significant immune activity and shares similarities with human pemphigus.

The study suggests that hypothyroidism may cause alopecia areata.

Hair loss in male pattern baldness is linked to changes in immune cell behavior around hair follicles.

Booster shots of mRNA vaccines for COVID-19 increased protective antibodies without worsening autoimmune skin conditions in patients.

People with alopecia areata have fewer IL-10 producing immune cells, which might contribute to the condition.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Nanoparticle-based herbal remedies could be promising for treating hair loss with fewer side effects and lower cost, but more research is needed.

Melanogenesis-related proteins may trigger immune responses in alopecia areata patients.

Scalp psoriasis features reversible hair loss and specific immune activation, with no significant hair follicle damage.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Small molecule DMF improves psoriasis and multiple sclerosis, adult skin cells can be made to grow new hair, certain skin cells initiate hair growth, IL-17C controls gut health and can cause skin inflammation, and skin cells produce IL-17 that can lead to psoriasis.

The document concludes that doctors should recognize congenital triangular alopecia to avoid unnecessary treatments, as it does not respond to steroids like alopecia areata does.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Lichen planopilaris may be an autoimmune disease causing hair loss due to immune system issues in hair follicles.

The new skin-targeted COVID-19 vaccine creates strong immune responses and could improve vaccination methods.

Ulcerative colitis can cause skin issues due to immune system problems.

Genetically repaired stem cells may treat certain genetic diseases, Th17 cells are key in fighting systemic fungal infections, hair loss in AGA is due to progenitor cell loss, and α-synuclein transfer might contribute to Parkinson's disease progression.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Frontal fibrosing alopecia is linked to increased immune system activity and reduced stem cells, suggesting early treatment targeting this pathway might prevent hair follicle damage.

EGCG may help treat alopecia areata by blocking certain immune responses and reducing specific harmful immune cells.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

A man developed myasthenia gravis after alopecia areata, and treatment improved his symptoms and stopped hair loss.

New treatments for Alopecia Areata, like JAK inhibitors, show promise for hair regrowth and are likely to change future treatment approaches.

Alopecia areata shows a unique type 1 interferon signature, suggesting potential treatment by targeting this pathway.

Hair gels may cause split ends in children.

Photodynamic therapy may not work for erythroplasia of Queyrat and could lead to invasive squamous cell carcinoma.

A woman with alopecia regrew her hair after taking a higher dose of tocilizumab.

High potency topical steroids are the most effective treatment for pediatric alopecia areata.